Synairgen Regulatory News (SNG)

30 Jun 2009 09:56



30 June 2009

Synairgen plc

("Synairgen" or "the Company")

Total Voting Rights

For the purposes of the Financial Services Authority's disclosure and Transparency Rules, the Company's total issued share capital at the date of this notice is 59,745,249. 

The Company's issued share capital consists of 59,745,249 ordinary shares of 1p each, with one voting right per share. There are no shares held in treasury.

The total number of voting rights in the Company is therefore 59,745,249.

The above figure of 59,745,249 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

For more information please contact:

Synairgen plc  Tel: + 44 (0) 2380 512 800

Richard Marsden, Managing Director

John Ward, Finance Director

Matrix Corporate Capital  Tel: + 44 (0) 20 3206 7000

Alastair Stratton

Anu Tayal

Threadneedle Communications  Tel: + 44 (0) 20 7653 9850

Graham Herring

Josh Royston